🔗 Share this article

An underground market for unlicensed weight-loss medications is being driven by social media fitness personalities and sellers on communication apps, according to recent findings.

Experimental Drug Gaining Popularity Online

Retatrutide, which is still in clinical trials, is being promoted by online personalities for its alleged fat-burning properties. Viewers are urged to message these accounts privately for source information, while also receiving promotional offers.

Thriving Trade on Social Networks

Separately, a robust trade exists on Telegram, where groups with numerous of members share comparison images, injection guides and claims of next-day UK delivery. Sellers market the substance there before directing buyers to other platforms for purchases.

Understanding The Experimental Drug

Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help patients lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Medical Experts Express Concerns

Nevertheless, physicians and chemists have warned that the sale of what remains an unapproved drug in the UK is a cause for concern and could lead to individuals administering substances of uncertain source.

Some experts said the demand for the experimental drug could be linked to the increasing price of licensed weight loss treatments such as Mounjaro.

Legal Position and Implementation

Selling the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unlicensed drug that must not be promoted or supplied for human use under the British medical regulations.

Several content creators try to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still breach pharmaceutical, marketing, and consumer regulations, potentially leading to fines, prosecution or imprisonment.

Platform Reaction and Content Elimination

According to TikTok, the service has removed problematic material and prohibited associated hashtags and search suggestions. The organization stated it was dedicated to maintaining the platform secure and allocating resources in strengthening compliance measures.

Online Marketplace Activities

Research also found communities with up to 9,000 participants selling retatrutide using Telegram's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” immediately brings up channels with numerous of members, filled with images of slimming results, glowing reviews and detailed guides for preparing or administering at residence.

After minutes of entering one community, a seller posted contact information, where the majority of purchases take place. The seller sent an instruction manual and promised delivery within 48 hours. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None asked about body mass, medical conditions or previous experience.

Product Information and Costs

Inside these communities, messages show black plastic packages with postal service labels, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at home with purified liquid, or ready-to-use injectors usually priced at £160 for 20mg. When asked how long a pen should last, sellers give conflicting answers ranging from a several days to “depends on your body”.

Platform Oversight and Security Actions

A spokesperson for Telegram said it regularly monitored dangerous material on its service including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are injecting substances they can’t verify. Even if the research behind retatrutide is valid, these digital products may not contain what they claim,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

A medical professional of an online medical service connected the surge in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With costs rising, individuals are using social media. But fake injections are highly risky. You cannot know what’s contained or whether the conditions they were made in was clean,” she said.

Her staff has previously encountered patients harmed by self-injection from unconfirmed sources. “We recognize the frustration, but purchasing from Telegram or WhatsApp is taking chances with your health,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”

Producer Position

A spokesperson from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency globally. “Therefore at this time no one can market [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a Lilly investigational substance not yet approved … may subject patients to potentially serious health risks”.